FdaApplication
ANDA 220296
Identifiers
- fda_app_no: ANDA220296
Properties
| Property | Value |
|---|---|
| applicant_name | ASPIRO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2026-03-17 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MICAFUNGIN SODIUM | MICAFUNGIN SODIUM | EQ 100MG BASE/VIAL | INJECTABLE;INTRAVENOUS |
| MICAFUNGIN SODIUM | MICAFUNGIN SODIUM | EQ 50MG BASE/VIAL | INJECTABLE;INTRAVENOUS |
2 products